Atai Life Sciences NV shares climbed after a psychedelic nasal spray from Beckley Psytech Ltd, the company it plans to ...

The companies are also running an open-label study to evaluate the long-term efficacy and safety of the therapy.

An experimental psychedelic therapy from the U.K. company Beckley Psytech significantly reduced symptoms of ...

Shares of atai Life Sciences (NASDAQ:ATAI) traded higher in the premarket on Tuesday after the company and its partner, ...

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...

Cosmo Feilding Mellen – currently Beckley's chief executive, who is slated to serve as chief strategy officer of the merged ...

Atai Life Sciences’ psychedelic drug has successfully reduced the symptoms of depression in a phase 2 study, triggering the next stage of the biotech’s planned merger with mental health company ...

A new study suggests that regular users of psychedelics may process self-related thoughts differently at both psychological ...

The government has permitted Dr. Cameron Lacey, a psychiatrist, to prescribe psilocybin, a hallucinogenic compound found in ...

A veteran advocating for the bill said psilocybin improved his PTSD symptoms after VA therapies failed to provide relief.

Colorado policymakers, including Gov. Jared Polis and Attorney General Phil Weiser, expressed enthusiasm about the potential ...